Previous Issues

Socialize

Information Links

Editor Guidelines Submit Manuscript Author Guidelines Reviewer Guidelines Processing Charges Publication Ethics FAQ's Contact Us

Volume 9, Issue 1 - 2024 Volume 8, Issue 4 - 2023 Volume 8, Issue 3 - 2023 Volume 8, Issue 2 - 2023 Volume 8, Issue 1 - 2023 Volume 7, Issue 3 - 2022 Volume 7, Issue 2 - 2022 Volume 7, Issue 1 - 2022 Volume 6, Issue 1 - 2021 volume 5, Issue 1 - 2020

Previous Issues

Volume 2, Issue 1 - 2017

Opinion Article

Advances in the Care of Diabetes and Cancer

Author : Daniela Capdepón^*
Citation : Capdepón D. (2017). Advances in the Care of Diabetes and Cancer. Mathews J Cancer Sci. 2(1): 013.

Research Article

Initial Response to Therapy with Fulvestrant and Cyclin-Dependent Kinase 4/6 Inhibitor in a Male with Stage IV Breast Cancer

Authors : Aurelio B. Castrellon*, Steven M. Nguyen, Adriana M. Milillo Naraine, Michel Velez, Luis E. Raez
Citation : Castrellon AB, Nguyen SM, Milillo Naraine AM, Velez M, et al. (2017). Initial Response to Therapy with Fulvestrant and Cyclin-Dependent Kinase 4/6 Inhibitor in a Male with Stage IV Breast Cancer.Mathews J Cancer Sci. 2(1): 012.

Research Article

Burden of Merkel Cell Carcinoma: A Targeted Literature Review

Authors : Siva Narayanan*, Smeet Gala
Citation : Narayanan S and Gala S. (2017). Burden of Merkel Cell Carcinoma: A Targeted Literature Review. Mathews J Cancer Sci. 2(1): 011.

Research Article

Flow Cytometric Analysis of Hyperfractionated and Hypofractionated Radiotherapy for Breast Cancer Patients

Authors : Hossam Donya^{1, 2*}, Mahmoud Moawad³
Citation : Donya H and Moawad M. (2017). Flow Cytometric Analysis of Hyperfractionated and Hypofractionated Radiotherapy for Breast Cancer Patients. Mathews J Cancer Sci. 2(1): 010.

Research Article

Anticancer Potential of EDTA: A Preliminary in Vitro Study

Authors : Loreto B. Feril Jr¹*, Koichi Ogawa¹, Akiko Watanabe¹, Ryohei Ogawa², Zheng-Guo Cui³, Takashi Kondo², Katsuro Tachibana¹
Citation : Feril LB Jr, Ogawa K, Watanabe A, Ogawa R, et al. (2017). Anticancer Potential of EDTA: A Preliminary in Vitro Study. Mathews J Cancer Sci. 2(1): 009.

Research Article

Using Immune Cells for Transport of Therapeutics to Brain Tumors

Author : Elena V. Batrakova¹
Citation : Batrakova EV. (2016). Using Immune Cells for Transport of Therapeutics to Brain Tumors. Mathews J Cancer Sci. 2(1): 008